Skip to main content

Full Schedule

Full Schedule

  • Thursday, October 23, 2025
  • 7:00 AM - 8:00 AM EDT
    PME Breakfast Symposium (non-CME) - Sponsored by Novo Nordisk.
  • 8:00 AM - 8:30 AM EDT
    Refresh and Recharge
  • 8:30 AM - 9:30 AM EDT
    Keynote Celebrating 20 Years of CMHC: From Prevention to Treatment to Cure
  • 9:30 AM - 11:00 AM EDT
    FDA Updates and Late Breaking Trials
  • 11:00 AM - 11:30 AM EDT
    Exhibit Hall Break
  • 11:30 AM - 12:30 PM EDT
    PME Lunch Symposium (non-CME) Aldosterone as an underlying driver of hypertension and CV and kidney
  • 12:30 PM - 1:00 PM EDT
    Exhibit Hall Break
  • 1:00 PM - 1:15 PM EDT
    Welcome & Opening Remarks
  • 1:15 PM - 1:45 PM EDT
    Innovative Approaches to Managing Resistant/Uncontrolled Hypertension: Screening, Evaluation and Intervention
  • 1:45 PM - 2:05 PM EDT
    Advancing Care in HFpEF
  • 2:05 PM - 2:25 PM EDT
    Avoiding Progression of CKD: Role of Aldosterone and Other Components of RAAS
  • 2:25 PM - 2:35 PM EDT
    Refresh and Recharge
  • 2:35 PM - 3:55 PM EDT
    Primetime CME Symposium: Transforming Cardiorenal Care - Timely Diagnosis and Guideline-driven Management of Heart Failure and Chronic Kidney Disease In Patients With or Without Type 2 Diabetes
  • 3:55 PM - 4:05 PM EDT
    Refresh and Recharge
  • 4:05 PM - 5:15 PM EDT
    Challenging Cardiorenal Cases with Expert Panel Discussion and Audience Q&A
  • 5:15 PM - 6:15 PM EDT
    Welcome Reception - Exhibit Hall
  • 6:15 PM - 7:15 PM EDT
    PME Dinner Symposium (non-CME) Tirzepatide: A Dual GIP and GLP-1 Receptor Agonist
  • Friday, October 24, 2025
  • 6:45 AM - 7:45 AM EDT
    PME Breakfast Symposium (non-CME) - Sponsored by Corcept Therapeutics.
  • 7:45 AM - 8:15 AM EDT
    Refresh and Recharge
  • 8:15 AM - 8:20 AM EDT
    Opening Remarks
  • 8:20 AM - 8:40 AM EDT
    The Importance of Healthy Lifestyle Behaviors in the Prevention of Cardiovascular Disease
  • 8:40 AM - 9:00 AM EDT
    Lancet Commission on Obesity
  • 9:00 AM - 9:30 AM EDT
    Updates in the Obesity Pharmacotherapy
  • 9:30 AM - 9:50 AM EDT
    GLP-1 RAs: Do They Benefit Patients with Alzheimer’s Disease, Addictive and Psychiatric Disorders?
  • 9:50 AM - 10:00 AM EDT
    Refresh and Recharge
  • 10:00 AM - 11:00 AM EDT
    Primetime CME Symposium MASH Uncovered: Essential Insights for Clinicians on Effective Screening, Risk Stratification, and Disease Management
  • 11:00 AM - 12:00 PM EDT
    Challenging Obesity & Lifestyle Management Cases with Expert Panel Discussion and Audience Q&A
  • 12:00 PM - 12:30 PM EDT
    Exhibit Hall Break
  • 12:30 PM - 1:30 PM EDT
    PME Lunch Symposium (non-CME) - Sponsored by Novo Nordisk.
  • 1:30 PM - 2:00 PM EDT
    Exhibit Hall Break
  • 2:00 PM - 3:10 PM EDT
    Primetime CME Symposium Innovative Approaches to ATTR-CM: Addressing Health Disparities in African American Populations
  • 3:10 PM - 3:15 PM EDT
    Opening Remarks
  • 3:15 PM - 3:35 PM EDT
    Bridging the Gap: Enhancing Understanding and Treatment of Diabetic Peripheral Neuropathy
  • 3:35 PM - 3:55 PM EDT
    Rethinking Diabetes: Understanding the Heterogeneity of Diabetes Typing
  • 3:55 PM - 4:05 PM EDT
    Refresh and Recharge
  • 4:05 PM - 4:25 PM EDT
    Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes
  • 4:25 PM - 5:30 PM EDT
    Challenging Diabetes Management Cases with Expert Panel Discussion and Audience Q&A
  • 5:30 PM - 6:30 PM EDT
    Happy Hour & Giveaways - Exhibit Hall
  • 6:30 PM - 7:30 PM EDT
    PME Dinner Symposium (non-CME) - Sponsored by Kiniksa Pharmaceuticals.
  • Saturday, October 25, 2025
  • 7:00 AM - 8:00 AM EDT
    PME Breakfast Symposium (non-CME) - Sponsored by Arrowhead Pharmaceuticals.
  • 8:00 AM - 8:30 AM EDT
    Refresh and Recharge Break
  • 8:30 AM - 8:35 AM EDT
    Opening Remarks
  • 8:35 AM - 9:35 AM EDT
    Current and Emerging Therapeutics in Hyperlipidemia
  • 9:35 AM - 10:20 AM EDT
    Emerging Therapies in Dyslipidemia: Spotlight on CETP Inhibitors
  • 10:20 AM - 10:35 AM EDT
    Refresh and Recharge
  • 10:35 AM - 11:15 AM EDT
    FCS, MCS, Persistent Chylomicronemia, sHTG: What do we do now?
  • 11:15 AM - 11:35 AM EDT
    Genetic Testing, Polygenic Risk Scores and Management of Cardiometabolic Disease
  • 11:35 AM - 11:55 AM EDT
    Targeting Inflammation in CVD: What is the Right Approach?
  • 11:55 AM - 1:25 PM EDT
    Challenging Lipid Management Cases with Expert Panel Discussion and Audience Q&A
  • 1:25 PM - 1:30 PM EDT
    Closing Remarks